Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UAA201601293ApriorityCriticalpatent/UA113597C2/en
Publication of UA113597C2publicationCriticalpatent/UA113597C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Винахід належить до медичної хімії, зокрема до синтезу речовин бенздіазепінового ряду, що мають високу анальгетичну та протизапальну активність, загальної формули І:R=СН, 4-Br-CH, 2-Cl, 3-Cl, 4-Cl-СН, 4-SCH-CH, 2-SCH.The invention relates to medical chemistry, in particular to the synthesis of substances of benzdiazepine series having high analgesic and anti-inflammatory activity, General formula I: R = CH, 4-Br-CH, 2-Cl, 3-Cl, 4-Cl-CH, 4 -SCH-CH, 2-SCH.
UAA201601293A2016-02-152016-02-15
3-ARILIDEN (HETARYLIDEN) -5- [2-aryl (HETARYL) VINYL] -1,3-DIGIDRO-2H-BENZO [e] [1,4] Diazepine-2-ones AS HIGHLY ACTIVE ANALGESPYALLY AND ANALGYPICALLY
UA113597C2
(en)
Compounds derived from prostaglandin e2 inhibitor 2-arylamino-benzimidazoles (mpges-1); pharmaceutical composition that includes them; intermediary compounds; use in the treatment of inflammatory diseases and / or associated conditions, in particular pain.
Compounds derived from 17-beta-cyano-18 alpha-homo-19-nor-androst-4-eno; presenting gestagenic and antimineralcorticoid activity; pharmaceutical composition; and use in the treatment of pre-peri-and postmenopausal disorders and premenstrual disorders.